Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant

Autor: Ane M. Andres, J Serradilla, Bárbara Pascual-Miguel, Paloma Talayero, Pablo Stringa, Alida Alcolea‐Sánchez, Alba Bueno, Martín Rumbo, Rodrigo Papa-Gobbi, Esther Ramos-Boluda, Francisco Hernández-Oliveros, Manuel López-Santamaría, Rocío González‐Sacristan
Jazyk: angličtina
Rok vydání: 2020
Předmět:
2019-20 coronavirus outbreak
CIENCIAS MÉDICAS Y DE LA SALUD
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
medicine.medical_treatment
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
viruses
SARS-COV-2
Medicina Clínica
030230 surgery
medicine.disease_cause
03 medical and health sciences
0302 clinical medicine
Virology
purl.org/becyt/ford/3.2 [https]
medicine
Letter to the Editor
Coronavirus
Transplantation
business.industry
TRANSPLANTATION
virus diseases
Severe acute respiratory syndrome coronavirus
COVID-19
Immunosuppression
body regions
Multivisceral transplantation
Infectious Diseases
Ciencias Médicas
MULTIVISCERAL TRANSPLANTATION
Coronavirus disease 2019 (covid-19)
Medicine
030211 gastroenterology & hepatology
purl.org/becyt/ford/3 [https]
Trasplantes
business
Zdroj: SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Transplant Infectious Disease
Popis: Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high-risk population. However, the evidence regarding their response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for COVID-19 is scant. Herein, we present the clinical and therapeutic course of a SARS-CoV-2 infection in a patient with multivisceral transplant and a recent tuberculosis infection.
Instituto de Estudios Inmunológicos y Fisiopatológicos
Databáze: OpenAIRE